Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes. / Kasprzycka, Monika; Majewski, Miroslaw; Wang, Zhi-Jong; Ptasznik, Andrzej; Wysocka, Maria; Zhang, Qian; Marzec, Michal; Gimotty, Phyllis; Crompton, Mark R.; Wasik, Mariusz A.
I: American Journal of Pathology, Bind 168, Nr. 5, 2006, s. 1631-1641.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes.
AU - Kasprzycka, Monika
AU - Majewski, Miroslaw
AU - Wang, Zhi-Jong
AU - Ptasznik, Andrzej
AU - Wysocka, Maria
AU - Zhang, Qian
AU - Marzec, Michal
AU - Gimotty, Phyllis
AU - Crompton, Mark R.
AU - Wasik, Mariusz A.
N1 - M1 - Copyright (C) 2018 American Chemical Society (ACS). All Rights Reserved. CAPLUS AN 2006:499467(Journal)
PY - 2006
Y1 - 2006
N2 - Tyrosine kinases play a fundamental role in cell proliferation, survival, adhesion, and motility and have also been shown to mediate malignant cell transformation. Here we describe constitutive expression of the protein tyrosine kinase Brk in a large proportion of cutaneous T-cell lymphomas and other transformed T- and B-cell populations. The kinase is expressed in the nuclear localization and activated state. Brk expression was also induced in normal T cells on their activation. Introduced expression of the Brk gene resulted in markedly diminished cytokine and growth factor dependence of transfected BaF3 lymphocytes in regard to their in vitro proliferation and survival. Brk also conferred in vivo oncogenicity on the BaF3 cells. SiRNA-mediated inhibition of the endogenous Brk in malignant T cells diminished their growth and survival capacity. These findings document inducible expression of Brk in normal T lymphocytes and persistent expression of the activated kinase in malignant T and B cells. Furthermore, our results indicate that Brk may play a key role in lymphomagenesis, hence identifying the kinase as a potential therapeutic target in lymphomas. [on SciFinder(R)]
AB - Tyrosine kinases play a fundamental role in cell proliferation, survival, adhesion, and motility and have also been shown to mediate malignant cell transformation. Here we describe constitutive expression of the protein tyrosine kinase Brk in a large proportion of cutaneous T-cell lymphomas and other transformed T- and B-cell populations. The kinase is expressed in the nuclear localization and activated state. Brk expression was also induced in normal T cells on their activation. Introduced expression of the Brk gene resulted in markedly diminished cytokine and growth factor dependence of transfected BaF3 lymphocytes in regard to their in vitro proliferation and survival. Brk also conferred in vivo oncogenicity on the BaF3 cells. SiRNA-mediated inhibition of the endogenous Brk in malignant T cells diminished their growth and survival capacity. These findings document inducible expression of Brk in normal T lymphocytes and persistent expression of the activated kinase in malignant T and B cells. Furthermore, our results indicate that Brk may play a key role in lymphomagenesis, hence identifying the kinase as a potential therapeutic target in lymphomas. [on SciFinder(R)]
KW - Brk IL3 T B cell lymphoma
U2 - 10.2353/ajpath.2006.050521
DO - 10.2353/ajpath.2006.050521
M3 - Journal article
VL - 168
SP - 1631
EP - 1641
JO - American Journal of Pathology
JF - American Journal of Pathology
SN - 0002-9440
IS - 5
ER -
ID: 202375956